Search results
Results from the WOW.Com Content Network
This article provides a list of autoimmune diseases. These conditions, where the body's immune system mistakenly attacks its own cells, affect a range of organs and systems within the body. Each disorder is listed with the primary organ or body part that it affects and the associated autoantibodies that are typically found in people diagnosed ...
The Journal of Proteome Research is a peer-reviewed scientific journal published since 2002 by the American Chemical Society. [1] Its publication frequency switched from bimonthly to monthly in 2006. The current editor-in-chief is John R. Yates .
A neuronopathy affects the cell body of a nerve cell in the peripheral nervous system. [5] Amyotrophic lateral sclerosis; Spinal muscular atrophy; Spinal muscular atrophy with respiratory distress type 1; Atypical motor neuron diseases; Dorsal root ganglion disorders
The complement system is part of the innate as well as the adaptive immune system; it is a group of circulating proteins that can bind pathogens and form a membrane attack complex. Complement deficiencies are the result of a lack of any of these proteins. They may predispose to infections but also to autoimmune conditions. [7]
Immune system disorders (10 C, 72 P) M. Musculoskeletal disorders (18 C, 86 P) N. Neurological disorders (13 C, 333 P) O. ... Category: Diseases and disorders by system.
Proteomic profiling is the large-scale analysis of proteins, which is essential for understanding biological processes and disease mechanisms.A proteomic profile may be employed to discover or diagnose diseases or conditions, which can monitor responses to therapeutic measures.
The Journal of Proteomics is a peer-reviewed scientific journal published by Elsevier. It is the official journal of the European Proteomics Association and the editor-in-chief is Juan Calvete. [1] It was established in 1979 as the Journal of Biochemical and Biophysical Methods, [2] obtaining its current name in 2008. [3]
An example thermal proteome profiling workflow. Binding of a drug to a protein often leads to ligand-induced stabilization of the protein (1), which can be measured by comparing the amount of non-denatured protein remaining in a drug-treated sample to an untreated control.